Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D organ printing. Matricelf Ltd was founded in 2019 and is based in Ness Ziona, Israel.
Stock data | 2024 | Change |
---|---|---|
Price | $0.9882735714769878 | N/A |
Market Cap | $15.64M | N/A |
Shares Outstanding | 15.82M | N/A |
Employees | 0 | N/A |